Blood · 1996 · 118 citations · 27 references
Life SciencesImmunologyOncologyCell SignalingSignal TransductionTumor ImmunologyInnate Immune ReceptorsInnate Immune RecognitionInnate Immune ResponseInnate Immune Signaling PathwaysKidney CancerRenal Cell CarcinomaAntibacterial Innate SignalingCytokine Signaling In CancerCytokine Signaling In TumorsCytokine Targeted TherapyInnate Antitumor ImmunityInterleukin Receptor SignalingInterleukin-13 Targeted TherapyTumor-associated Cytokines
We have previously shown that human renal cell carcinoma (RCC) cells express large numbers of interleukin-13 receptors (IL-13R), a newly described hemopoietic growth factor receptor. To target tumor cells that express IL-13R, we have produced a chimeric protein composed of human IL-13 and a derivative of Pseudomonas exotoxin A, termed PE38QQR. We report here that IL13-PE38QQR is highly cytotoxic to many human RCC cell lines. IL-13R-negative cell lines or cell lines expressing low numbers of IL-13R ( < 300 sites/cell) that include human bone marrow-derived cells were not susceptible to the cytotoxic effect of IL 13-PE38QQR. The sensitivity of RCC cells to IL13-PE38QQR correlated positively with the density of IL-13R. The cytotoxic activity of IL13-PE38QQR was competed by an excess of IL-13 in a protein synthesis inhibition assay and confirmed by a clonogenic assay. Even though IL-13 and IL-4 are homologues and IL-4R and IL-13R have been proposed to share a receptor subunit, IL-4 did not compete for the cytotoxicity mediated by IL13-toxin on RCC. IL13-PE38QQR competes for [125I]-IL-13 binding sites on RCC cells, although at a lower affinity than the wild-type recombinant cytokine. Human T-cell, B-cell, and monocytic cell lines are unresponsive to the cytotoxic action of IL13-PE38QQR. Thus, our results indicate that IL13-PE38QQR is highly cytotoxic to human RCC cells, although it is not cytotoxic to a variety of normal hematopoietic cells. IL13-PE38QQR should be further investigated preclinically for the treatment of human RCCs.
27
lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses
A Minty, Pascale Chalon, Jean‐Marie Derocq et al. · Nature · 1993 · 892 citations
René de Waal Malefyt, Carl G. Figdor, Richard Huijbens et al. · The Journal of Immunology · 1993 · 649 citations
Interleukin 13 is a B cell stimulating factor.
Thierry Defrance, P Carayon, Gisèle Billian et al. · The Journal of Experimental Medicine · 1994 · 297 citations · Full text